Researcher’s Profile

Xiaojuan (Jan) Chen, MD, PhD

Principal Investigator, Columbia Center for Translational Immunology
Director of Islet Cell Transplantation, Columbia Center for Translational Immunology
Principal Investigator, Naomi Berrie Diabetes Center

Dr. Chen’s research is focused on pancreatic islets, which contain insulin-secreting beta cells and glucagon-secreting alpha cells, both important for maintaining blood glucose homeostasis. The main research goal of the Chen lab is to explore areas of islet cellular and molecular biology that are pertinent to the development of diabetes as well as to the improvement of islet transplantation for the treatment of type 1 diabetes. In addition, the laboratory aims to, by working closely with immunologists at the CCTI, develop clinically applicable strategies for the induction of donor specific transplantation tolerance in islet transplant recipients. Current lines of investigation include:

1. Studies on the physiology of human islet alpha and beta cells including their paracrine interaction as part of an effort in understanding the abnormalities in hormonal secretion by islets in both type 1 and type 2 diabetes.

2. Studies on the immunogenicity of beta cells potentially contributed to the development of type 1 diabetes under different pathophysiological conditions.

3. Studies on the induction of specific tolerance to allogeneic islet transplants by an approach which utilizes mixed bone marrow chimerism and T-regulatory cells.

4. Studies on developing approaches that optimize islet cell survival and function during islet processing, culture and engraftment.

5. Studies on islet beta cell replication including the mechanisms and the limiting factors involved. These studies will allow us to gain greater insights into the fundamental physiological mechanisms that govern the normal growth and functioning of pancreatic islets. In addition, it will provide a physiological basis to identify targets in signaling pathways that would be useful to design potential therapeutic strategies to generate new beta cells to prevent and/or cure type 1 and type 2 diabetes.

The future goals of the laboratory are to pursue each of the areas in more depth both physiologically and mechanistically and to continually pinpoint areas of therapeutic potential, particularly in preventing islet dysfunction during the development of diabetes as well as in preventing auto- and allo-immunity against islets.

Lab Members: 
Sean Cambell, M.D., Ph.D., Postdoc
Wei Liu, M.D., Graduate student
Neranjan Shanthilal de Silva, Undergraduate student
Collaborators: 
<p> Dr. Megan Sykes</p> <p> Dr. Dieter Egli&nbsp;</p>
Publications: 
Woodland D, Wei Liu, Liang J, Sears M, Chen X. Short-term high fat feeding induces islet macrophage infiltration and -cell replication independent of cellular oxidative stress. AJP-Endocrinology & Metabolism 2016 (in revision) Liao S, Liu Y, Chen X, Tan Y, Mei J, Dong W, Gan L, Wang H, Yin S, dong X, Chi S, Deng S.  The impact of genetic variants for different physiological characterization of type 2 diabetes loci on gestational insulin signaling in non-diabetic pregnant Chinese women.  Reproductive Sciences. Epub 2015 April 14. Liao S, Mei J, Song W, Chi S, Liu Y, Chen X, Deng S. The impact of the new international association of diabetes and pregnancy study groups (IADPSG) fasting glucose diagnostic criterion on the prevalence and outcomes of gestational diabetes mellitus in Chinese women.  Diabetic Medicine 2014; 31(3)341-51; Epub 2013 Nov 22. Rink SJ, McMahon MK, Zhang X, Chen X, Mirkin AC, Thaxton SC, Kaufman DB.  IκB kinase-β knockdown by spherical nucleic acid conjugates prevents cytokine-induced injury and enhances islet graft survival. Transplantation 2013; 96(10):877-884 Muayed ME, Raja MR, Zhang X, MacRenaris K, Bhatt S, Nagle AP, Hungness ES, Chen X, Urbanek M, O’Halloran TV, Lowe WL.  Accumulation of cadmium in insulin producing beta cells.  Islets. 2012; 4(6):405-416 Liao S, Liu Y, Tan Y; Gan L, Mei J, Song W, Chi S, Dong X, Chen X, Deng S. Association of genetic variants of melatonin receptor B with gestational plasma glucose level and risk of glucose intolerance in pregnant Chinese women.  PloS ONE 2012; 7(7):e40113. Epub 2012 Jul 2. Rink SJ, Chen X, Zhang X, Kaufman DB.  Conditional and specific inhibition of NF-κB in mouse pancreatic β-cells prevents cytokine-induced deleterious effects and improves islet survival post-transplant. Surgery 2012; Feb;151(2):330-9. Epub 2011 Oct 6. Rink SJ, McMahon KM, Chen X, Mirkin CA, Thaxton CS, Kaufman DB. 2010, Transfection of pancreatic islets using polyvalent DNA-functionalized gold nanoparticles.  Surgery 2010;148:335-45. Chen X*, Larson CS, West J, Zhang X, Kaufman DB. In vivo detection of extra-pancreatic insulin gene expression in diabetic mice by bioluminescence imaging. PLoS ONE 2010; Feb 24, 5(2): e9397.  Chen X*, Zhang X, Chen F, Larson CS, Wang L, Kaufman DB. Comparative study of regenerative potential of β-cells from young and aged donor mice using a novel islet transplantation model.  Transplantation 2009, 88(4):496-503.  Chen X, Zhang X, Larson CS, Xia G, Kaufman DB. Prolonging islet allograft survival using in vivo bioluminescence imaging to guide timing of anti-lymphocyte serum treatment of rejection.  Transplantation 2008, 85(9):1246-52 Chen X, Zhang X, Larson CS, Kissler H, Kaufman DB.  The epididymal fat pad as a transplant site for minimal islet mass.  Transplantation 2007, 84(9):122-5. Chen X, Zhang X, Larson CS, Baker MS, Kaufman DB. Visualization of Islets after Transplantation and Early Detection of Graft Rejection by In Vivo Bioluminescence Imaging. Transplantation 2006, 81:1421-7. Baker MS, Chen X, Rotramel AR, Nelson, JJ, Kaufman DB.  Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates effector cell infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients.  Surgery 2003, 134:126-33. Baker MS, Chen X, Rotramel AR, Nelson JJ, Kaufman DB. Interferon regulatory factor-1 down-regulates cytokine-induced IP-10 expression in pancreatic islets.  Surgery 2003, 134:134-41. Baker MS, Chen X, Rotramel A, Nelson J, Kaufman DB.  Proinflammatory Cytokines Induce NF-kB-Dependent/NO-Independent Chemokine Gene Expression in MIN6 β Cells.  J Surg Res 2003, 110: 295-303. Kaufman DB, Baker MS, Chen X, Leventhal JR, Stuart FP. Sequential Kidney/Islet Transplantation Using Prednisone-Free Immunosuppression. American. J. Transplantation 2002, 2: 674 – 677. Wu JJ, Chen X, Cao XC, Baker MS, Kaufman DB. Cytokine-Induced Metabolic Dysfunction of MIN6 β-Cells is Nitric Oxide Independent.  J. Surg. Res. 2001, 101: 190 – 5. Baker MS, Chen X, Cao XC, Kaufman DB. Expression of a Dominant Negative Inhibitor of NF-κB Protects MIN6 β-cells From Cytokine-Induced Apoptosis.  J. Surg. Res. 2001, 97 (2): 117- 22. Kessler PD, Podsakoff GM, Chen X, McQuiston S, Colosi P, Matelis LA, Kurtzman GJ, & Byrne BJ. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein.  Proc. Natl. Acad. Sci. USA 1996, 93:14082-14087. Chen X, Horseman ND. Cloning, expression, and mutational analysis of the pigeon prolactin receptor.  Endocrinology 1994, 133:269-276. Horseman ND, Chen X, Liu L, Poyet P, & Hitti Y.  Cell and species distribution of prolactin-inducible annexin I mRNA.  Gen. Comp. Endocrinol. 1992, 85: 405 – 414.
About: 

Dr. Xiaojuan Chen is a principal investigator at the CCTI and serves as Director of Islet Cell Transplantation of CCTI and the Director of Columbia Islet Processing Core at the Columbia University College of Physicians and Surgeons. Dr. Chen received her M.D. degree from Jinan University Medical College, China, M.S. degree in Biology from Marquette University, and Ph.D degree in Molecular and Cellular Physiology from University of Cincinnati, followed by a postdoctoral training at the John’s Hopkins University. She joined Columbia University in 2012 after spending 15 years at Northwestern University School of Medicine, where she conducted translational research in islet cell transplantation. Having become an expert in the exacting methodology and compliance procedures required for FDA-approved clinical cellular therapies, Dr. Chen performed islet isolation from more than 180 pancreata for research and clinical islet transplantation to patients with type 1 diabetes.

At Columbia, her laboratory is conducting research on human islet cell biology and immunogeneicity characterization, and utilizes islet transplantation models to explore areas of islet cellular and molecular biology that are pertinent to the development of diabetes as well as to the improvement of islet transplantation for the treatment of type 1 diabetes. In addition, Dr. Chen will direct a nonhuman primate research program in tolerance induction to islet allografts. Using both animal models and human islets, she will play a key role in translating tolerance therapies from animal models to the clinic. For more information on current research, please see research description and publications.